ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/11/2026
Back to search
Official data from USPTO
VELOCITY PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
02/12/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
02/06/2022
Registration date
03/14/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/14/2023
Last transaction
02/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
02/01/2019
First use in commerce
02/01/2019
Drawing code
3
Owner type
03
Owner location
MELVILLE, NY
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylistic emblem resembling the shape of a flower and star in blue. To the right of the stylistic emblem are the stylized words "VELOCITY PHARMA" in black font.
Holders and representatives
Holders
SOLIS PHARMACEUTICALS INC.
Velocity Pharma LLC
Representatives
ERYN Y. TRUONG LOZA & LOZA, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Allergy medications; Pain relief medications
Publications
History of USPTO decisions and trademark events.
15 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/14/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/27/2022
PUBO
PUBLISHED FOR OPPOSITION
12/27/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/19/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/19/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/19/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/19/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/19/2022
DOCK
ASSIGNED TO EXAMINER
11/17/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/10/2022
NWAP
NEW APPLICATION ENTERED
02/09/2022
Continuous trademark protection
Get notified about every new filing that threatens VELOCITY PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.